Innovative personalised collagen- and
gelatine-based implants manufactured
with 3D technology for patients suffering
from osteoarticular diseases.
Improving existing treatments for patient around the world
Our research is focused on improving patients’ lifes. We aim at developing an innovative treatment for millions of patients worldwide suffering from tendinopathies and osteoarthritis (OA), a health problem that especially affects the elderly, women and professional athletes.
The TriAnkle project is presented at the annual conference of the Centre for Biomedical Research Network (CIBER BBC) held on 15 and 16 November online. In this conference, the 43 research groups that make up the CIBER BBN explain the projects they are working on. One of these is Nanobiocel, a research group of the Pharmacy and Pharmaceutical Technology Laboratory
Dr. Lluis Quintana, Corporate Manager Viscofan BioEngineering, presents the TriAnkle project at the seventh edition of the Freiberg Collagen Symposium, on September 30th. The Freiberg Collagen Symposium, held every four years in this German city, is a benchmark for experts and professionals in the field of research and the collagen industry. It is an unmissable event that allows them to
Sharing our TriAnkle project with our colleagues of OAFI in their Symposium #ArticulatingTheSport for joint health prevention and recovery in sports practice. Lluis Quintana and Achim Weber present our promising treatment for regenerating tendons and cartilages. An event co-organized with the Spanish Olympic Committee (COE), and the Foundation and Medical Services Of Atlético De Madrid Football Club.
Dr. Lluis Quintana presents the TriAnkle project at #SportsTomorrow 2020 of the Barça Innovation Hub, which counts with more than 2,000 attendees. The spotlight for sports innovation that brings together leading experts to inspire coaches, analysts, doctors, nutritionists, physiotherapists, sport scientists, marketeers and sport executives.
The TriAnkle consortium – made up of 12 European organisations, has signed its grant agreement by which it comes into operation and will develop 3D bioprinted personalised scaffolds for tissue regeneration of ankle joints. This ambitious research project in regenerative medicine comes with an overall budget of €5.9M and will be developed over 4 years, starting January 2021.
This project has received funding from the European Union’s Horizon 2020
research and innovation framework programme under the Grant Agreement #952981